Mostrar o rexistro simple do ítem

Long-term (104-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)

dc.contributor.authorGómez-Reino Carnota, Juan Jesús 
dc.date.accessioned2017-06-07T07:10:41Z
dc.date.available2017-06-07T07:10:41Z
dc.date.issued2015
dc.identifier.issn0315-162X
dc.identifier.urihttp://hdl.handle.net/20.500.11940/3490
dc.language.isoeng
dc.titleLong-term (104-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)
dc.typePublicación de congreso
dc.authorsophosGladman, D
dc.authorsophosKavanaugh, A
dc.authorsophosMease, P
dc.authorsophosAdebajo, A
dc.authorsophosGomez-Reino, J
dc.authorsophosHall, S
dc.authorsophosLespessailles, E
dc.authorsophosSchett, G
dc.authorsophosShah, K
dc.authorsophosHu, CC
dc.authorsophosStevens, R
dc.authorsophosWollenhaupt, J
dc.identifier.isi357280700088
dc.identifier.sophos18861
dc.issue.number7
dc.journal.titleJOURNAL OF RHEUMATOLOGY
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Reumatoloxía
dc.rights.accessRightsopenAccess
dc.typesophosComunicaciones a congresos
dc.volume.number42


Ficheiros no ítem

FicheirosTamañoFormatoVer

Non hai ficheiros asociados a este ítem.

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem